查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722870

病毒載體製造市場規模、佔有率、趨勢及預測（按類型、疾病、應用、最終用戶和地區），2025 年至 2033 年

Viral Vector Manufacturing Market Size, Share, Trends and Forecast by Type, Disease, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球病毒載體製造市場規模價值 14.696 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 85.122 億美元，2025 年至 2033 年的複合年成長率為 21.6%。北美目前佔據市場主導地位，2024 年的市佔率將超過 49.3%。遺傳疾病盛行率的上升、基因療法的採用率的提高、先進的生物技術基礎設施、不斷擴大的臨床試驗、強大的政府資金、強勁的研發投資以及領先製藥公司的存在推動了北美病毒載體製造市場的發展。

病毒載體是分子生物學家用來將遺傳物質運送到細胞的工具。它用於替代缺陷基因以治療遺傳疾病，並透過模仿自然感染來表達和呈現致病抗原以產生免疫反應。它廣泛用於溶瘤療法以靶向和殺死腫瘤細胞。除此之外，由於它有助於治療不同的疾病，如心臟缺陷、代謝疾病和神經退化性疾病，因此它在生命科學研究、基因治療和疫苗學中得到廣泛的應用。目前，由於體內基因突變和染色體受損導致的遺傳疾病的盛行率不斷上升，病毒載體的生產也在增加。

病毒載體製造市場趨勢：

由於人們飲酒量增加和久坐不動的生活方式導致癌症患者增加是推動市場成長的關鍵因素之一。此外，全球範圍內針對病毒載體進行的臨床研究數量也在增加。這一點，加上病毒載體在新型藥物傳輸中的日益廣泛的應用，正在對市場產生積極的影響。除此之外，它們也是病毒禁用序列的有效載體，並用於將抑制愛滋病毒的基因改造遞送至人類造血幹細胞（HSC）。此外，一些國家的政府正在發起活動，提高人們對病毒載體疫苗的認知。他們也透過快速核准流程等變革來改善監管環境。此外，主要市場參與者正在全球大力投資擴大製造活動的產能。這些參與者也熱衷於併購（M&A），預計這將增加他們的整體銷售額和獲利能力。

本報告回答的關鍵問題

  • 什麼是病毒載體製造？全球病毒載體製造市場有多大？
  • 2025-2033年全球病毒載體製造市場的預期成長率是多少？
  • 推動全球病毒載體製造市場的關鍵因素有哪些？
  • 根據類型，全球病毒載體製造市場的主要部分是什麼？
  • 根據疾病，全球病毒載體製造市場的主要部分是什麼？
  • 根據應用，全球病毒載體製造市場的領導部分是什麼？
  • 全球病毒載體製造市場的關鍵區域有哪些？
  • 全球病毒載體製造市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球病毒載體製造市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 腺病毒載體
  • 腺相關病毒載體
  • 慢病毒載體
  • 逆轉錄病毒載體
  • 其他

第7章：市場區隔：依疾病

  • 癌症
  • 遺傳性疾病
  • 傳染病
  • 其他

第 8 章：市場區隔：按應用

  • 基因治療
  • 疫苗學

第9章：市場區隔：依最終用戶

  • 製藥和生物製藥公司
  • 研究機構

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Cognate BioServices Inc. (Charles River Laboratories International Inc.)
    • F. Hoffmann-La Roche AG
    • FinVector Oy
    • FUJIFILM Holdings Corporation
    • Kaneka Eurogentec SA (Kaneka Corporation)
    • Lonza Group AG
    • Merck KGaA
    • Oxford Biomedica plc
    • REGENXBIO Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • uniQure NV
Product Code: SR112025A5016

The global viral vector manufacturing market size was valued at USD 1,469.6 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 8,512.2 Million by 2033, exhibiting a CAGR of 21.6% from 2025-2033. North America currently dominates the market, holding a market share of over 49.3% in 2024. The rising prevalence of genetic disorders, increasing adoption of gene therapies, advanced biotechnology infrastructure, expanding clinical trials, strong government funding, robust R&D investments, and the presence of leading pharmaceutical companies drive the viral vector manufacturing market in North America.

A viral vector is a tool used by molecular biologists for delivering genetic materials into cells. It is used to replace defective genes for curing genetic disorders and express and present pathogenic antigens for generating an immune response by mimicking a natural infection. It is widely employed in oncolytic therapies to target and kill tumor cells. Besides this, as it assists in treating different diseases, such as heart defects, metabolic diseases, and neurodegenerative disorders, it finds extensive applications in life science research, gene therapy and vaccinology. At present, there is a rise in viral vector manufacturing on account of the rising prevalence of genetic disorders due to a combination of gene mutations and damaged chromosomes in the body.

Viral Vector Manufacturing Market Trends:

The increasing cancer patients due to the rising alcohol consumption and sedentary lifestyles of individuals represents one of the key factors contributing to the growth of the market. In addition, there is a rise in the number of clinical studies undertaken on viral vectors across the globe. This, along with the growing utilization of viral vectors in novel drug delivery, is positively influencing the market. Besides this, they are efficient carriers of virus-disabling sequences and are used to deliver HIV-inhibiting transgenes to human hematopoietic stem cells (HSCs). Additionally, governments of several countries are launching campaigns to generate awareness about viral vector vaccines among individuals. They are also improving the regulatory environment via changes, such as fast-track approval processes. Furthermore, key market players are extensively investing in capacity expansion for manufacturing activities around the world. These players are also indulging in mergers and acquisitions (M&A), which is projected to increase their overall sales and profitability.

Key Market Segmentation:

Breakup by Type:

  • Adenoviral Vectors
  • Adeno-associated Viral Vectors
  • Lentiviral Vectors
  • Retroviral Vectors
  • Others

Breakup by Disease:

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Others

Breakup by Application:

  • Gene Therapy
  • Vaccinology

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Research Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cognate BioServices Inc. (Charles River Laboratories International Inc.), F. Hoffmann-La Roche AG, FinVector Oy, FUJIFILM Holdings Corporation, Kaneka Eurogentec S.A. (Kaneka Corporation), Lonza Group AG, Merck KGaA, Oxford Biomedica plc, REGENXBIO Inc., Sanofi S.A., Thermo Fisher Scientific Inc. and uniQure N.V.

Key Questions Answered in This Report

  • 1.What is viral vector manufacturing?
  • 2.How big is the global viral vector manufacturing market?
  • 3.What is the expected growth rate of the global viral vector manufacturing market during 2025-2033?
  • 4.What are the key factors driving the global viral vector manufacturing market?
  • 5.What is the leading segment of the global viral vector manufacturing market based on type?
  • 6.What is the leading segment of the global viral vector manufacturing market based on disease?
  • 7.What is the leading segment of the global viral vector manufacturing market based on application?
  • 8.What are the key regions in the global viral vector manufacturing market?
  • 9.Who are the key players/companies in the global viral vector manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viral Vector Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Adenoviral Vectors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Adeno-associated Viral Vectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lentiviral Vectors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Retroviral Vectors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Disease

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Genetic Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Infectious Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Vaccinology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Cognate BioServices Inc. (Charles River Laboratories International Inc.)
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 F. Hoffmann-La Roche AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 FinVector Oy
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 FUJIFILM Holdings Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Lonza Group AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Biomedica plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 REGENXBIO Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 uniQure N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Viral Vector Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Viral Vector Manufacturing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Viral Vector Manufacturing Market: Breakup by Disease (in %), 2024
  • Figure 6: Global: Viral Vector Manufacturing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Viral Vector Manufacturing Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Viral Vector Manufacturing Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Viral Vector Manufacturing (Adenoviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Viral Vector Manufacturing (Adeno-associated Viral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Viral Vector Manufacturing (Lentiviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Viral Vector Manufacturing (Retroviral Vectors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Viral Vector Manufacturing (Retroviral Vectors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Viral Vector Manufacturing (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Viral Vector Manufacturing (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Viral Vector Manufacturing (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Viral Vector Manufacturing (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Viral Vector Manufacturing (Genetic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Viral Vector Manufacturing (Genetic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Viral Vector Manufacturing (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Viral Vector Manufacturing (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Viral Vector Manufacturing (Other Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Viral Vector Manufacturing (Other Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Viral Vector Manufacturing (Gene Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Viral Vector Manufacturing (Gene Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Viral Vector Manufacturing (Vaccinology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Viral Vector Manufacturing (Vaccinology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Viral Vector Manufacturing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Viral Vector Manufacturing (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Viral Vector Manufacturing (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Viral Vector Manufacturing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Viral Vector Manufacturing Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Viral Vector Manufacturing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Viral Vector Manufacturing Industry: SWOT Analysis
  • Figure 85: Global: Viral Vector Manufacturing Industry: Value Chain Analysis
  • Figure 86: Global: Viral Vector Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viral Vector Manufacturing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Viral Vector Manufacturing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Viral Vector Manufacturing Market Forecast: Breakup by Disease (in Million USD), 2025-2033
  • Table 4: Global: Viral Vector Manufacturing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Viral Vector Manufacturing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Viral Vector Manufacturing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Viral Vector Manufacturing Market: Competitive Structure
  • Table 8: Global: Viral Vector Manufacturing Market: Key Players